Innovative sunscreen formulation based on benzophenone-3-loaded chitosan-coated polymeric nanocapsules

Skin Pharmacology and Physiology

Volumn 24, Issue 3, 2011, Pages 166-174

  Siqueira, N M ^a   Contri, R V ^a   Paese, K ^a   Beck, R C R ^a   Pohlmann, A R ^a   Guterres, S S ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Benzophenone 3; Cationic coating; Chitosan; Hydrogel; Nanocapsules; Skin permeation penetration; Sunscreen

Indexed keywords

CATION; CHITOSAN; HYDROXYETHYLCELLULOSE; NANOCAPSULE; NANOPARTICLE; OXYBENZONE; POLYCAPROLACTONE; POLYMER;

ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; DRUG COATING; DRUG FORMULATION; DRUG SYNTHESIS; HUMAN; HUMAN CELL; HUMAN TISSUE; HYDROGEL; IN VITRO STUDY; LOADING DRUG DOSE; PHOTON CORRELATION SPECTROSCOPY; PRIORITY JOURNAL; SKIN PENETRATION; TRANSMISSION ELECTRON MICROSCOPY; ZETA POTENTIAL;

ADMINISTRATION, CUTANEOUS; ANIMALS; BENZOPHENONES; CELLULOSE; CHITOSAN; HYDROGELS; MICROSCOPY, ELECTRON, TRANSMISSION; NANOCAPSULES; PARTICLE SIZE; POLYESTERS; SKIN ABSORPTION; SUNSCREENING AGENTS; SWINE;

EID: 79151474631     PISSN: 16605527     EISSN: None     Source Type: Journal    
DOI: 10.1159/000323273     Document Type: Article

References (38)

1. Gonzalez H, Farbrot A, Larkö O, Wennberg AM: Percutaneous absorption of the sun-screen benzophenone-3 after repeated whole-body applications, with and without ultraviolet irradiation. Br J Dermatol 2006; 154:337-340. (Pubitemid 43382707)
2. Cross SE, Innes B, Roberts MS, Tsuzuki T, Robertson TA, McCormick P: Human skin penetration of sunscreen nanoparticles: in vitro assessment of a novel micronized zinc oxide formulation. Skin Pharmacol Physiol 2007; 20:148-154. (Pubitemid 46788286)
3. Mavon A, Miquel C, Lejeune O, Payre B, Moretto P: In vitro percutaneous absorption and in vivo stratum corneum distribution of an organic and a mineral sunscreen. Skin Pharmacol Physiol 2007; 20:10-20. (Pubitemid 46005806)
4. Okereke CS, Kadry AM, Abdel-Rahman MS, Davis FA, Friedman MA: Metabolism of benzophenone-3 in rats. Drug Metab Dispos 1993; 21:788-791. (Pubitemid 23298440)
5. Felix T, Hall B, Brodbelt JS: Determination of benzophenone-3 and metabolites in water and human urine by solid-phase microex-traction and quadrupole ion trap GC-MS. Anal Chim Acta 1998; 371: 195-203. (Pubitemid 28401472)
6. Sarveiya V, Risk S, Benson HAE: Liquid chromatographic assay for common sun-screen agents: application to in vivo assess-ment of skin penetration and systemic ab-sorption in human volunteers. J Chromatogr B Analyt Technol Biomed Life Sci 2004; 803: 225-231. (Pubitemid 38452442)
7. Hayden CG, Roberts MS, Benson HA: Sys-temic absorption of sunscreen after topical application. Lancet 1997; 350: 863-864. (Pubitemid 27404352)
8. Gustavsson-Gonzalez H, Farbrot A, Larkö O: Percutaneous absorption of benzophe-none-3, a common component of topical sunscreens. Clin Exp Dermatol 2002; 27:691-694. (Pubitemid 35454233)
9. Vidal L, Chisvert A, Canals A, Salvador A: Sensitive determination of free benzophe-none-3 in human urine samples based on an ionic liquid as extractant phase in single-drop microextraction prior to liquid chro-matography analysis. J Chromatogr A 2007; 1174:95-103. (Pubitemid 350116813)
10. Schlumpf J, Cotton B, Conscience M, Haller V, Steinmann B, Lichtensteiger W: In vitro and in vivo estrogenicity of UV screens. En-viron Health Perspect 2001; 109: 239-244. (Pubitemid 32331514)
11. Schlumpf M, Schmid P, Durrer S, Con-science M, Maerkel K, Henseler M, Gruetter M, Herzog I, Reolon S, Ceccatelli R, Faass O, Stutz E, Jarry H, Wuttke W, Lichtensteiger W: Endocrine activity and developmental toxicity of cosmetic UV filters: an update. Toxicology 2004; 205:113-122. (Pubitemid 39349158)
12. Schmutzler C, Hamann I, Hofmann PJ, Ko-vacs G, Stemmler L, Mentrup B, Schomburg L, Ambrugger P, Grüters A, Seidlova-Wuttke D, Jarry H, Wuttke W, Köhrle J: Endocrine active compounds affect thyrotropin and thyroid hormone levels in serum as well as endpoints of thyroid hormone action in liver, heart and kidney. Toxicology 2004; 205: 95-102. (Pubitemid 39349156)
13. Morohoshi K, Yamamoto H, Kamata R, Shi-raishi F, Koda T, Morita M: Estrogenic activ-ity of 37 components of commercial sun-screen lotions evaluated by in vitro assays. Toxicol In Vitro 2005; 19: 457-469.
14. Rhodes MC, Bucher JR, Peckham JC, Kissling GE, Hejtmancik MR, Chhabra RS: Carcinogenesis studies of benzophenone in rats and mice. Food Chem Toxicol 2007; 45: 843-851. (Pubitemid 46452882)
15. Maier T, Korting HC: Sunscreens: which and what for? Skin Pharmacol Physiol 2005; 18: 253-262.
16. Fernandez C, Nielloud F, Fortuné R, Vian L, Marti-Mestres G: Benzophenone-3: rapid prediction and evaluation using non-inva-sive methods of in vivo human penetration. J Pharm Biomed Anal 2002; 28:57-63. (Pubitemid 34171646)
17. Paese K, Jäger A, Poletto F, Pinto EF, Rossi-Bergmann B, Pohlmann AR, Guterres SS: Semisolid formulation containing a nanoen-capsulated sunscreen: effectiveness, in vitro photostability and immune response. J Biomed Nanotechnol 2009; 5:240-246.
18. Jiménez MM, Pelletier J, Bobin MF, Martini MC: Influence of encapsulation on the in vi-tro percutaneous absorption of octyl me-thoxycinnamate. Int J Pharm 2004; 272:45-55. (Pubitemid 38293010)
19. Weiss-Angeli V, Poletto FS, Zancan LR, Bal-dasso F, Pohlmann AR, Guterres SS: Nano-capsules of octyl methoxycinnamate con-taining quercetin delayed the photodegrada-tion of both components under ultraviolet A radiation. J Biomed Nanotechnol 2008; 4:80-89.
20. Luengo J, Weiss B, Schneider M, Ehlers A, Stracke F, König K, Kostka K-H, Lehr C-M, Schaefer UF: Influence of nanoencapsula-tion on human skin transport of flufenamic acid. Skin Pharmacol Physiol 2006; 19: 190-197. (Pubitemid 44114517)
21. Lademann J, Richter H, Schaefer UF, Blume-Peytavi U, Teichmann A, Otberg N, Sterry W: Hair follicles: a long-term reservoir for drug delivery. Skin Pharmacol Physiol 2006; 19: 232-236. (Pubitemid 44114522)
22. Calvo P, Vila-Jato JL, Alonso MJ: Evaluation of cationic polymer-coated nanocapsules as ocular drug carriers. Int J Pharm 1997; 153: 41-50. (Pubitemid 27283332)
23. de Campos AM, Sánchez A, Gref R, Calvo P, Alonso MJ: The effect of PEG versus a chito-san coating on the interaction of drug col-loidal carriers with the ocular mucosa. Eur J Pharm Sci 2001; 20:73-81. (Pubitemid 37103234)
24. Dodane V, Khan MA, Merwin JR: Effect of chitosan on epithelial permeability and structure. Int J Pharm 1999; 182: 21-32. (Pubitemid 29229791)
25. Valenta C, Auner BG: The use of polymers for dermal and transdermal delivery. Eur J Pharm Biopharm 2004; 58: 279-289. (Pubitemid 39037235)
26. Fessi H, Puisieux F, Devissaguet J, Ammo-ury N, Benita S: Nanocapsule formation by interfacial polymer deposition following sol-vent displacement. Int J Pharm 1989; 55:R1-R4. (Pubitemid 19247505)
27. Briceño MI: Rheology of suspensions and emulsions; in Nielloud F, Marti-Mestres G (eds): Pharmaceutical Emulsions and Sus-pensions. New York, Marcel Dekker, 2000.
28. Alves MP, Scarrone AL, Santos M, Pohl-mann AR, Guterres SS: Human skin pene-tration and distribution of nimesulide from hydrophilic gels containing nanocarriers. Int J Pharm 2007; 341: 215-220. (Pubitemid 47088101)
29. Braun DB, Rosen MR: Rheology Modifiers Handbook. Practical Use and Application. New York, William Andrew, 2000.
30. Schmid-Wendtner MH, Korting HC: The pH of the skin surface and its impact on the bar-rier function. Skin Pharmacol Physiol 2006; 19: 296-302. (Pubitemid 44808083)
31. Guaratini T, Gianeti MD, Campos PM: Sta-bility of cosmetic formulations containing esters of vitamins E and A: chemical and physical aspects. Int J Pharm 2006; 327:12-16. (Pubitemid 44767660)
32. Alves MP, Pohlmann AR, Guterres SS: Semi-solid topical formulations containing nime-sulide-loaded nanocapsules, nanospheres or nanoemulsion: development and rheological characterization. Pharmazie 2005; 60:900-904. (Pubitemid 41820755)
33. Terroso T, Külkamp IC, Jornada DS, Pohl-mann AR, Guterres SS: Development of semi-solid cosmetic formulations contain-ing coenzyme Q10-loaded nanocapsules. Lat Am J Pharm 2009; 28: 819-826.
34. Celia C, Trapasso E, Cosco D, Paolino D, Fresta M: Turbiscan Lab® Expert analysis of the stability of ethosomes® and ultradeform-able liposomes containing a bilayer fluidiz-ing agent. Colloids Surf B Biointerfaces 2009; 72:155-160.
35. Rinaudo M: Chitin and chitosan: properties and applications. Prog Polym Sci 2006; 31: 603-632. (Pubitemid 44287019)
36. de Campos AM, Sánchez A, Alonso MJ: Chi-tosan nanoparticles: a new vehicle for the im-provement of the delivery of drugs to the oc-ular surface-application to cyclosporin A. Int J Pharm 2001; 224:159-168. (Pubitemid 32706495)
37. Lboutounne H, Chaulet JF, Ploton C, Falson F, Pirot F: Sustained ex vivo skin antiseptic activity of chlorhexidine in poly(-cap-rolactone) nanocapsule encapsulated form and as a digluconate. J Control Release 2002; 82: 319-334. (Pubitemid 34880187)
38. Alvarez-Román R, Naika A, Kalia YN, Guy RH, Fessi H: Skin penetration and distribu-tion of polymeric nanoparticles. J Control Release 2004; 99: 53-62. (Pubitemid 39165733)